DK120190B - Analogifremgangsmåde til fremstilling af terapeutisk aktive 17-estere af 9α,11β-dihalogen-16α-alkyl-Δ<1,4>-pregnadien-17α,21-diol-3,20-dioner. - Google Patents

Analogifremgangsmåde til fremstilling af terapeutisk aktive 17-estere af 9α,11β-dihalogen-16α-alkyl-Δ<1,4>-pregnadien-17α,21-diol-3,20-dioner.

Info

Publication number
DK120190B
DK120190B DK407467AA DK407467A DK120190B DK 120190 B DK120190 B DK 120190B DK 407467A A DK407467A A DK 407467AA DK 407467 A DK407467 A DK 407467A DK 120190 B DK120190 B DK 120190B
Authority
DK
Denmark
Prior art keywords
pregnadiene
diones
dihalo
diol
esters
Prior art date
Application number
DK407467AA
Other languages
English (en)
Inventor
L Finckenor
E Shapiro
E Collins
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of DK120190B publication Critical patent/DK120190B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
DK407467AA 1966-08-11 1967-08-10 Analogifremgangsmåde til fremstilling af terapeutisk aktive 17-estere af 9α,11β-dihalogen-16α-alkyl-Δ<1,4>-pregnadien-17α,21-diol-3,20-dioner. DK120190B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57172166A 1966-08-11 1966-08-11

Publications (1)

Publication Number Publication Date
DK120190B true DK120190B (da) 1971-04-26

Family

ID=24284775

Family Applications (1)

Application Number Title Priority Date Filing Date
DK407467AA DK120190B (da) 1966-08-11 1967-08-10 Analogifremgangsmåde til fremstilling af terapeutisk aktive 17-estere af 9α,11β-dihalogen-16α-alkyl-Δ<1,4>-pregnadien-17α,21-diol-3,20-dioner.

Country Status (7)

Country Link
US (1) US3422193A (da)
CH (1) CH504423A (da)
DE (1) DE1643033B2 (da)
DK (1) DK120190B (da)
FR (2) FR8355M (da)
GB (1) GB1193464A (da)
NL (1) NL6710908A (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1643036B2 (de) * 1967-08-16 1976-04-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue 11 beta-halogensteroide, diese enthaltende arzneimittel sowie verfahren zu ihrer herstellung
US4323564A (en) * 1977-04-28 1982-04-06 Syntex (U.S.A.) Inc. Esters of 6-chloro-11β, 17α,21-trihydroxypregna-1,4,6-triene-3,20-dione
DE2735110A1 (de) * 1977-08-04 1979-02-15 Hoechst Ag Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung
US4154748A (en) * 1978-01-20 1979-05-15 The Upjohn Company Phosphate catalyzed acylation of steroidal tertiary alcohols
JPS6040439B2 (ja) * 1978-03-29 1985-09-11 大正製薬株式会社 ヒドロコルチゾン誘導体
DE3068965D1 (en) * 1979-11-16 1984-09-20 Sterosynt Ltd 6-alpha-fluoro-16-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them
DE3260474D1 (en) * 1981-02-02 1984-09-06 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
DE3133081A1 (de) * 1981-08-18 1983-03-10 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue 6(alpha)-methylprednisolon-derivate, ihre herstellung und verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3201391A (en) * 1959-02-18 1965-08-17 Syntex Corp 6alpha, 9alpha, 11beta-trichloro and 6alpha-fluoro-9alpha, 11beta-dichloro pregnenes
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
US3324110A (en) * 1965-02-05 1967-06-06 Schering Corp Method of phosphorylation and novel intermediates produced thereby

Also Published As

Publication number Publication date
DE1643033A1 (de) 1971-01-07
FR1566176A (da) 1969-05-09
CH504423A (de) 1971-03-15
NL6710908A (da) 1968-02-12
GB1193464A (en) 1970-06-03
FR8355M (da) 1971-02-08
DE1643033B2 (de) 1976-09-30
US3422193A (en) 1969-01-14

Similar Documents

Publication Publication Date Title
DK128353B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive bis-chromoner.
DK129835B (da) Analogifremgangsmåde til fremstilling af 2-chlor-6α-fluor-16α-methyl-pregna-1,4-dien-3,20-dioner.
DK119557B (da) Analogifremgangsmåde til fremstilling af 17α-benzoyloxy-9α-fluor-16β-methyl-Δ&lt;1,4&gt;-pregnadien-11β, 21-diol-3,20-dion.
DK120190B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive 17-estere af 9α,11β-dihalogen-16α-alkyl-Δ&lt;1,4&gt;-pregnadien-17α,21-diol-3,20-dioner.
DK123170B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 3-oxo-7α-methyl-Δ&lt;4,9,11&gt;-estratriener.
DK128352B (da) Analogifremgangsmåde til fremstilling af 9α-fluor-11β-hydroxypregna-1,4-dien-3,20-dion-[17α,16α-d]-oxazolidinoxaziner.
DK120337B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 3-keto-6-halogen-9β10α-Δ&lt;4,6&gt;-steroiddiener af androstan- eller pregnanrækken.
DK126111B (da) Fremgangsmåde til fremstilling af Δ&lt;5,10&gt;-steroider med cyclopentanoperhydrophenanthrenstruktur.
DK115547B (da) Fremgangsmåde til fremstilling af 17α-acyloxy-16-methyl-9α-flour-Δ&lt;1,4&gt;-pregnadien-3,20-dioner.
DK113640B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 9α,11β-dihalogen-pregna-1,4-dien-[17α,16α-d]-oxazolin-3,20-dioner.
DK112235B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 21-dicyclohexylmethylcarbonater af 21-hydroxy-Δ&lt;4&gt;-pregnen-17α-ol-3,20-dioner.
DK122453B (da) Analogifremgangsmåde til fremstilling af 21-estere af 6α,9α-dihalogen-16α-methyl-Δ&lt;1,4&gt;-pregnadien-11β,21-diol-3,20-dioner.
DK117488C (da) Fremgangsmåde til fremstilling af terapeutisk aktive 2α-3α-epithio-5α-androstaner.
DK121053B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 6α,9α,21-trihalogen-16α-methyl-11β-hydroxy-1,4-pregnadien-3,20-dioner.
DK116658B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ&lt;5&gt;-østrener.
DK124822B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 16α-thiosubstituerede 9β, 10α-pregn-4-en-3,20-dioner.
DK122763B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive 1,2α-methylen-4-pregnen-3,20-dionderivater.
DK113146B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 6-halogen-1α,2α-methylen-16α-methyl-&amp;Delta&lt;4,6&gt;-pregnadien-17α-ol-3,20-dioner eller deres 17-estere.
DK132121B (da) Fremgangsmåde til fremstilling af 17alfa-hydroxypregna-4,9(11)-dien-3,20-dion.
DK121510B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ&lt;5(10)&gt;-østrener.
DK126937B (da) Fremgangsmåde til fremstilling af 4,6-dihalogen-16-alkyliden-17α-hydroxy-pregna-4,6-dien-3,20-dioner.
DK118237B (da) Analogifremgangsmåde til fremstilling af 17α, 21-diestere af 9α, 11β-dichloro-16α-methyl-1,4-pregnadien-17α, 21-diol-3, 20-dion.
DK112168B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 17-estere af 16α-halogen-6α-methyl-17α-hydroxy-4-pregnen-3,20-dioner.
DK117897B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 21-trialkylsiloxypregnan-3,20-dioner.
DK115548B (da) Fremgangsmåde til fremstilling af betændelseshæmmende 9α,11β-substituerede 16β-methyl-17α-propionyloxy-Δ&lt;1,4&gt;-pregnadien-3,20-dioner.